Literature DB >> 16377428

Occurrence of cognitive impairment after age 90: MCI and other broadly used concepts.

Philippe P Pioggiosi1, Domenico Berardi, Barbara Ferrari, Roberto Quartesan, Diana De Ronchi.   

Abstract

BACKGROUND: Few data are available on the impact of applying different concepts to define cognitive impairment among nonagenarians and centenarians. This study explored the occurrence of four broadly used concepts in an over 90-year-old population. DESIGN/
METHODS: We examined a community-based cohort of 34 people with a mean age (+/- S.D.) of 96.4 (+/- 3.9) years, living in Bologna (Italy). We calculated the proportion of subjects that was given a diagnosis of cognitive impairment according to the following four commonly used concepts: Mild Cognitive Impairment (MCI), Age-Associated Memory Impairment (AAMI), Cognitive Impairment, No Dementia (CIND), and Questionable Dementia stage of the Clinical Dementia Rating (CDR 0.5).
RESULTS: The proportion of subjects with cognitive impairment varied from 5.9%, according to CIND, to 32.4%, according to MCI. The four concepts identified different groups of subjects as having cognitive impairment, and no subject was given a diagnosis of cognitive impairment according to all four concepts.
CONCLUSION: Commonly used criteria for diagnosis of cognitive impairment can differ by a factor of five in the number of subjects they classified as impaired. Such disagreement has serious implications for prevention, as people with a mild cognitive impairment may be a suitable target group for interventions before the development of dementia.

Entities:  

Mesh:

Year:  2005        PMID: 16377428     DOI: 10.1016/j.brainresbull.2005.06.039

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  8 in total

1.  Neuropsychological Test Norms in Cognitively Intact Oldest-Old.

Authors:  Zarui A Melikyan; Maria M Corrada; Malcolm B Dick; Christina Whittle; Annlia Paganini-Hill; Claudia H Kawas
Journal:  J Int Neuropsychol Soc       Date:  2019-05       Impact factor: 2.892

2.  Cognitive impairment in nondemented oldest-old: prevalence and relationship to cardiovascular risk factors.

Authors:  Carrie B Peltz; María M Corrada; Daniel J Berlau; Claudia H Kawas
Journal:  Alzheimers Dement       Date:  2011-11-04       Impact factor: 21.566

3.  Mild cognitive impairment, dementia, and their subtypes in oldest old women.

Authors:  Kristine Yaffe; Laura E Middleton; Li-Yung Lui; Adam P Spira; Katie Stone; Caroline Racine; Kristine E Ensrud; Joel H Kramer
Journal:  Arch Neurol       Date:  2011-05

Review 4.  Classification and epidemiology of MCI.

Authors:  Rosebud Roberts; David S Knopman
Journal:  Clin Geriatr Med       Date:  2013-11       Impact factor: 3.076

5.  Autonomic function predicts cognitive decline in mild cognitive impairment: Evidence from power spectral analysis of heart rate variability in a longitudinal study.

Authors:  Paola Nicolini; Tiziano Lucchi; Carlo Abbate; Silvia Inglese; Emanuele Tomasini; Daniela Mari; Paolo D Rossi; Marco Vicenzi
Journal:  Front Aging Neurosci       Date:  2022-09-15       Impact factor: 5.702

6.  Neuropsychological Criteria for Mild Cognitive Impairment in the Framingham Heart Study's Old-Old.

Authors:  Christina G Wong; Kelsey R Thomas; Emily C Edmonds; Alexandra J Weigand; Katherine J Bangen; Joel S Eppig; Amy J Jak; Sherral A Devine; Lisa Delano-Wood; David J Libon; Steven D Edland; Rhoda Au; Mark W Bondi
Journal:  Dement Geriatr Cogn Disord       Date:  2018-11-02       Impact factor: 2.959

7.  Is there a neuropathology difference between mild cognitive impairment and dementia?

Authors:  Vahram Haroutunian; Lisa B Hoffman; Michal Schnaider Beeri
Journal:  Dialogues Clin Neurosci       Date:  2009       Impact factor: 5.986

Review 8.  Mild cognitive impairment: when nutrition helps brain energy rescue-a report from the EuGMS 2020 Congress.

Authors:  Stephen C Cunnane; Cornel C Sieber; Russell H Swerdlow; Alfonso J Cruz-Jentoft
Journal:  Eur Geriatr Med       Date:  2021-07-05       Impact factor: 1.710

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.